92.5 A+
Gonadorelin
Also known as: GnRH, Factrel, Lutrepulse
FDA Approved Research Chemical
Research Evidence 90.0/100
Safety Profile 95.0/100
122 Clinical Trials
Unknown: 13 PHASE4: 13 PHASE3: 27 PHASE2, PHASE3: 5 PHASE2: 26 PHASE1, PHASE2: 3 PHASE1: 8 NA: 27
- Aurora Test for ART Donor Patients (AURORA-Donor) Unknown Phase RECRUITING Fertiga, Belgium
- MEDAM (Menopur Retrospective Data prograM) Unknown Phase COMPLETED Ferring Pharmaceuticals
- Mental Wellbeing and Quality of Life in Prostate Cancer Unknown Phase COMPLETED King's College London
- First-line Palbociclib and Endocrine Therapy for Patients With HR+/HER2- Advanced Breast Cancer in the Real-world Setting. Unknown Phase ACTIVE_NOT_RECRUITING Pfizer
- Study to Assess the Design of Use of REKOVELLE® in Women Undergoing In Vitro Fertilisation or Intracytoplasmic Sperm Injection Procedures in Routine Clinical Practice Unknown Phase COMPLETED Ferring Pharmaceuticals
Showing 5 of 122 trials.
20 Research Papers
- THE GONADOTROPIN RELEASING HORMONE AGONIST, DESLORELIN ACETATE, IS CONTRAINDICATED FOR MITIGATION OF AGGRESSION AND REPRODUCTIVE BEHAVIOR IN MALE COWNOSE RAYS (RHINOPTERA BONASUS). J Zoo Wildl Med unknown
- Comparative effectiveness of curettage, uterine artery embolization, and gonadotropin-releasing hormone (GnRH) agonist therapy in the management of acquired uterine enhanced myometrial vascularity/arteriovenous malformation (EMV/AVM) and retained products of conception (RPOC): A retrospective cohort study. Int J Gynaecol Obstet unknown
- Correction: Severe ovarian hyperstimulation syndrome following sole gonadotropin-releasing hormone (GnRH) agonist trigger: a case series and literature review. Arch Gynecol Obstet unknown
- An explainable machine learning model for identifying the risk of suboptimal oocyte maturation in patients with polycystic ovary syndrome undergoing GnRH-antagonist protocol. J Ovarian Res unknown
- Robust serotonin activation of the kisspeptin GnRH pulse generator in male and female mice. Endocrinology unknown
Showing 5 of 20 papers by citation count.
FDA Data
Not FDA-Approved
Gonadorelin has not been evaluated by the FDA for safety or efficacy. It is not approved for human therapeutic use in the United States.
Frequently Asked Questions
Is Gonadorelin FDA approved?
No, Gonadorelin has not been approved by the FDA for human therapeutic use. It is sold as a research chemical.
How many clinical trials has Gonadorelin been studied in?
Gonadorelin has been studied in 122 registered clinical trials. CheckPeptides tracks phase, status, and sponsor data for each trial.
What is the trust score for Gonadorelin?
Gonadorelin has a CheckPeptides trust score of 92.5/100 (grade: A+). This score is based on clinical trial volume, research paper quality, FDA data, and evidence classification.
Last verified: April 8, 2026
Quick Facts
- Classification
- GnRH analogue
- Molecular Weight
- 1182.3 Da
- PubChem
- CID 638793 ↗
- Regulatory Status
- N/A
Score Breakdown
Research Evidence 90.0/100
Safety Profile 95.0/100
Evidence Summary
- Clinical Trials
- 122
- Research Papers
- 20
- Trust Score
- 92.5/100
- Grade
- A+